Disease-modifying agents in rheumatoid arthritis.
Lipsky
P E
PE
D000209:Acute-Phase Proteins / Q000378:metabolism; D000962:Antimalarials / Q000494:pharmacology / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D006051:Aurothioglucose / Q000494:pharmacology / Q000627:therapeutic use; D003864:Depression, Chemical; D006052:Gold Sodium Thiomalate / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D010396:Penicillamine / Q000494:pharmacology / Q000627:therapeutic use; D010586:Phagocytes / Q000187:drug effects; D013601:T-Lymphocytes / Q000187:drug effects
D000209:Acute-Phase Proteins; D000962:Antimalarials; D006052:Gold Sodium Thiomalate; D006051:Aurothioglucose; D010396:Penicillamine